help@researchreport.co.uk

Filter By Price






Report Type
 
The  global  medical  devices  (MD)  market  represents  a  steady  growing  industrial  sector  as  well  as  an  attractive  investment  opportunity  for  profitable  rewards.  However,  the  potential  for  greater  investment  return  may  be  constrained  by  a  number  of  barriers  and  risks  in  global  medical  device  market  —  most  notably,  maturing  industry  growth  stage,  challenging  and  changing  regulatory  laws  and  procedures,  and  declining  profit  margins.  Hence,  in-depth  information  and  enhanced  strategic  intelligence  are  needed  to  minimize  the  potential  risks  associated  with  new  entrants  into  the  global  medical  device  industry.

This  report  focuses  on  systematic  evaluation  and  analysis  of  Internal  Risks  (arising  within  the  industry  development  itself)  and  External  Risks  (arising  from  the  surrounding  environments)  in  global  medical  devices  industry  and  market.  The  major  internal  risks  recognized  in  this  industry  include  industry  growth  stage,  industry  competition  pressure,  market  entry  barriers,  industry  volatility,  and  technology  challenge.  The  major  external  risks  include  factors  like  profit  decline,  regulation  force,  effect  of  foreign  direct  investment,  and  other  risks  (namely  shortage  of  upstream  supply,  competition  from  substitutes,  and  purchase  potential  decrease).  
The  risk  evaluation  and  threat  rating  concentrate  on  worldwide  medical  device  market  under  the  industry  conditions  and  environments  in  2014.  Forecasts  and  projections  have  been  performed  for  the  trend  of  industry  risk  over  the  next  six  years  (2014-2020).  All  the  identified  risk  factors  are  measured  quantitatively  according  to  GMD’s  novel  numeric  system,  i.e.  each  risk  is  evaluated  with  GMD  Risk  Index  Number  (GMD  RIN)  and  GMD  Risk  Intensity  Level  (GMD  RIL).  These  in-depth  appraisals  and  analysis  about  risk  considerations  &  controls  provide  a  comprehensive  understanding  of  the  current  risk  factors  and  likelihood  of  risk  development  trends.  Moreover,  this  report  also  provides  wise  risk  management  strategies  and  concludes  Critical  Success  Factors  (CSFs)  to  help  identify  fresh  growth  point  and  overcome  the  threats  and  obstacles  of  doing  manufacture/business  in  global  medical  device  industry.


Companies  Mentioned
Johnson  &  Johnson
GE  Healthcare
Medtronic  Inc.

Siemens  AG  
Baxter  International  Inc.

Fresenius  Medical  Care  AG  &  Co.  KGAA  
Koninklijke  Philips  NV  
Cardinal  Health  Inc.

Novartis  AG
Covidien  plc  
Stryker  Corp.

Becton,  Dickinson  and  Co.

Boston  Scientific  Corp.  
Essilor  International  SA
Allergan  Inc.  
St.  Jude  Medical  Inc.  
3M  Co.  
Abbott  Laboratories
Zimmer  Holdings  Inc.  
Terumo  Corp.


Predicted  by  Grace  Market  Data,  the  global  medical  devices  (MD)  market  will  see  a  steady  growth  over  the  coming  years  with  the  sales  revenue  and  international  trade  value  reaching  $543.9  bn  and  $289.2  bn  respectively  by  2020  driven  by  aging  population,  increasing  healthcare  expenditure  and  technology  advancement.

Global  Medical  Devices  Market  2012-2020  examines  the  worldwide  market  of  medical  devices  through  a  comprehensive  review  of  information  sources.  This  report  provides  historical  performance,  in-depth  analysis  and  trend  forecast  of  market  size  and  share,  sales  revenue,  international  trade,  R&D  investment,  geographic  distributions  and  product  categories  by  device  area  in  the  global  medical  device  market  and  industry.  Historical  statistics  cover  the  past  three  years  and  forecast  data  characterize  the  2014-2020  period.

Market  analyses  and  discussions  of  commercial  drivers,  restraints  and  challenges,  emerging  market  opportunities,  competitive  environment  and  technological  developments  are  also  reviewed  in  the  report.  Geographic  sub-markets  include  continents  such  as  North  America,  Europe,  Asia  Pacific  region,  Latin  America  and  the  rest  of  world,  with  12  country-based  markets  analyzed  in  detail  for  market  overview,  industry  landscape,  healthcare  system  and/or  regulation  issues.  Per  capita  MD  expenditure/availability  in  major  economic  markets  (on  country  basis)  is  compared  and  analyzed.  Medical  devices  are  segmented  by  device  area  such  as  Diagnostic  Imaging  Devices,  In  Vitro  Diagnostics,  Cardiology,  Orthopedics,  Ophthalmics,  General  and  Plastic  Surgery,  Endoscopy,  Dental,  Diabetic  Care,  Wound  Management,  Nephrology,  General  Hospital  and  Healthcare,  Ear,  Nose  and  Throat,  Neurology  and  others.  The  market  data  and  forecast  trends  are  provided  for  each  sub-market  in  the  time  range  of  2012-2020,  highlighted  by  62  tables  and  figures  totally.  The  top  40  medical  device  manufacturers  in  2014  are  listed  and  20  of  them  are  profiled  and  studied.


Companies  Mentioned
Johnson  &  Johnson
GE  Healthcare
Medtronic  Inc.

Siemens  AG  
Baxter  International  Inc.

Fresenius  Medical  Care  AG  &  Co.  KGAA  
Koninklijke  Philips  NV  
Cardinal  Health  Inc.

Novartis  AG
Covidien  plc  
Stryker  Corp.

Becton,  Dickinson  and  Co.

Boston  Scientific  Corp.  
Essilor  International  SA
Allergan  Inc.  
St.  Jude  Medical  Inc.  
3M  Co.  
Abbott  Laboratories
Zimmer  Holdings  Inc.  
Terumo  Corp.


The global Steel Cord market will reach xxx Million USD in 2018 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Steel Cord by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.


Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Normal Tensile (NT)
        High Tensile (HT)
        Others


Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
        Bekaert
        Jiangsu Xingda Steel Cord
        ArcelorMittal
        Hyosung
        Shandong SNTON Steel Cord
        Bridgestone
        Shougang Century
        Tokusen
        Tokyo Rope MFG
        Hubei Fuxing New Material
        BMZ
        Henan Hengxing
        Junma Tyre Cord
        Sumitomo Electric Industries
        Sodetal


Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        Passenger Car Use
        Freight Car Use
        Others


Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa

Needle-Free IV Connectors can be defined as needleless devices that are used for connecting administration sets, syringes, as well as IV catheters. Based upon internal characteristic and functioning of the parts, these connectors are segmented as simple and complex.

Simple connectors comprise of stationary internal parts. Complex connectors work as per the internal parts movement. The simple connector’s market segment command the major share of the products utilized in the healthcare delivery. The fluid displacement as well as pathway is determined by the internal parts motion namely mechanical valve that can control the fluid movement and direction in complex connectors. Some external characteristics such as housing, shape, and color for both type of connectors may or may not be same. The goal of using needle-free IV connectors include ease in infusion for care providers as well as patients, limiting the needle-stick injuries risk among the health care providers as well as limiting the  bacterial and microbial contamination risk.

As per the World Health Organization (WHO), around 1 million deaths over the year are linked with the inappropriate use of syringes and needles that can be limited by utilizing needle-free IV connectors. Certain dreadful diseases such as hepatitis as well as HIV can spread through inappropriate as well as reuse of needles and syringes. The unsafe usage of injections accounts for over 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections across the globe. The needle stick injuries though uncommon but pose a potential problem, that prove to be serious and may cause the above mentioned diseases. As per the Centers for Disease Control and Prevention (CDC), in the U.S., over 385,000 healthcare workers suffer from needle stick injuries in a year. The most important aim of using IV administration sets as well as needle-free connectors is to limit the manipulation factor as much as possible. One-Link, CARESITE, MaxPlus, and Kendall are among the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors.

North America command the majority share in the global needle-free connectors market, Europe commands the second largest share in the global market. Factors such as the rise in geriatric population as well as chronic diseases lead to large revenue of North American market.  As per the Centers for Disease Control and Prevention (CDC), over half of the  American adults, suffer from either one or more chronic health conditions and one among four adults suffer from two or more chronic health conditions. The major factors driving the growth of the needle-free IV connectors market includes government investments and funding in order to improve healthcare infrastructure, high awareness among people, as well as healthcare practitioners. For instance, the National Healthcare Safety Network (NHSN) as well as Center for Disease Control and Prevention (CDC) in the year 2013, conducted surveillance methods in order to identify and track device-linked infections by setting the guidelines for the prevention of central-line linked bloodstream infections. Furthermore, as per the World Health Organization (WHO) chronic diseases was the major cause of mortality in Europe in the year 2013 with around one-third of the European population falling in the age group above 15 suffering with a chronic disease and over two out of three people falling in the age group of 60 age had at least two chronic conditions.

Some of the industry players in needle free IV connectors market include CareFusion Corporation, RyMed Technologies, LLC, Baxter International Inc., Becton, Dickinson and Company, Nexus Medical LLC, ICU Medical, Inc., B. Braun Melsungen AG, and Vygon SA.

Absorbable nasal implants help to treat nasal blockage as well as obstructions and support better breathing and aid in sleeping to the patient. Several factors may lead to nasal airway obstruction that include deviation of septum, enlargement of turbinates, and weakening of upper and/or lower lateral nasal wall cartilage that can result into nasal valve collapse or vestibular stenosis. The symptoms of nasal valve collapse include stuffiness, and inability to breathe through one or both nostrils.  The nasal valve collapse leads to over 80% of the total airway resistance. Over 3 million Americans consult physician for nasal obstruction and around 1 million procedures are conducted to ease the symptoms.

The patient’s quality of life is significantly impacted by nasal valve collapse. This condition is may be severe in some patients, and result in limited number of treatment options. Also, majority of the treatment options are invasive and the only solution is to undergo a nasal valve surgery. This needs broad skills as well as training by either an ENT specialist or facial plastic surgeons.

The most common options is the nasal valve dilator for instance, Breathe Right strips are available in the market. Two options are available in case of nasal valve dilators. One that can be internally worn and the other that is externally stuck externally. The other available option is rhinoplasty with or without graft in order to repair the collapse of nasal valve collapse.

Owing to low patient awareness, this nasal condition is either undertreated or under diagnosed. An absorbable implant can be defined as non-invasive technology in order to support the nasal cartilage as well as improve breathing.  These implants are an important milestone development for nasal obstruction patients as standard treatment procedure for septum as well as turbinates are not enough. The implants are mostly preferred for patients who have undergone a rhinoplasty since there is a likelihood of an extremely narrow-looking nose.

Two brands are available in the global absorbable nasal implants market namely, Latera, and Inex. Latera is an absorbable nasal implant produced from Spirox Inc. that received the FDA approval in the year 2016.  The other absorbable nasal implant, INEX was approved by the U.S. FDA in the year 2015. INEX absorbable nasal implant aids septal cartilage whereas the LAtera supports upper as well as lower lateral nasal cartilage.

Latera is designed with the help of a copolymer, that gets absorbed in the body over a duration of over 18 months. The product comprises of delivery device as well as an implant positioning guide in the accessories. The single use delivery device comprises of a handle body, a deployment plunger and pushrod, as well as 16-gauge delivery cannula with a depth marker and protective cover.

As absorbable nasal implant is an innovative product, the market for this device is very small and will find the acceptance among the physicians and patients with high level of awareness.

The major industry players in absorbable nasal implant market include Acclarent, Inc., ArthroCare Corporation, Pfizer, Inc., Spirox, Inc., Mentor Worldwide LLC, Smith & Nephew, Inc., Intersect ENT, Inc., and Stryker Corporation, among others. 

An electric wheelchair, also referred to as power wheelchair is a wheelchair that is driven with the help of an electric motor and not manual efforts. These electric wheelchairs are light-weight and provide mobility in a light package. The electric wheelchairs provide compact size, and are ideal for confined spaces and narrow doorways..

Factors promoting the rate of adoption of electric wheelchairs include ease of mobility, increasing elderly population across the globe, convenience, and high demand for advanced wheelchairs from the sports industry, as large number of sports events are planned for disabled persons for example wheelchair basketball, wheelchair rugby, and others. Also, the increasing automation trend resulting in enhanced investment returns and cost optimization are futher driving the market growth. These electric chairs are durable, adjustable as well as possess special seats with soft pads especially for orthopedic patients. Rise in aged population, requirement of automated wheelchair for disabled population and rise in disposable income of people are the major factors fuelling the wheelchairs market growth.

However, factors such as high price of electric wheel chair as well as lack of awareness and infrastructure, such as broken pathways, non-availability of ramps in buses & trains for wheelchair users hamper the rate of adoption of electrical wheelchairs.

The global wheelchairs market is segmented based on product type and region. Depending on product type, the wheelchairs market is classified into centre wheel drive, front wheel drive, standing electric wheelchair, rear wheel drive, and others. Among these market segments, the centre and front wheel drive segments are high in demand and comprise of combined market share of over 60% in global electric wheelchairs market.

Rise in the number of spinal cord injuries, elderly population, technological enhancements and high rate of adoption of artificial intelligence are factors propelling the high adoption of electrical wheelchairs. In the U.S, there is a rise in the number of serious traumatic spinal cord injuries owing to accidents and falls. The present number of senior citizens are highly active thereby resulting in balance and cognitive issues that contributes to high risk for falls.

In the developing economies, there is an excessive demand for automation and automatic operation of wheelchairs among customers. The major factors leading to high rate of adoption of automated electric wheelchairs include busy lifestyle and sophistication in daily life activities. Owing to an increase in the working professionals as well as elderly population, there are time constraints for offering assistance with manual wheelchairs, which has led to an increased demand for power wheelchairs. Additionally, electric wheelchairs provide independence as well as convenience of usage that provides ease of control resulting  in instantaneous turns as well as path changing options.

Some of the industry players in wheelchairs market include GF Health Products, Inc., Pride Mobility Products Corp., OttoBock Healthcare GmbH, LEVO AG Sunrise Medical Limited, Drive Medical Ltd., Karman Healthcare, Permobil AB, Invacare Corporation, and MEYRA GmbH.

Medical alert systems (MAS), also referred to as personal emergency response system (PERS), are alarm systems especially modeled in order to alert linked healthcare facilities in instances of a medical hazard or injury that would require immediate medical attention. These alert systems are often marketed along with a wireless transmitter developed as a pendant,  that can be triggered in a medical emergency. The major end-users of these alert systems include disabled and elderly people who live separately from their family members. The major factors propelling the growth of the medical alert systems market include rapidly aging population and high awareness among the population. The other factors promoting the growth of this market include technical developments in healthcare wearables market, progression in communication and connectivity technologies, and mobility benefits offered by these devices.

The global medical alert systems market has been segmented on the basis of device type, technology, end users and region. Based on device type, the global medical alert systems market can be segmented into mobile, landline and standalone/wall mounted devices. On the basis of technology, the global market can be sub divided into two-way voice systems, unmonitored medical alert systems, and medical alert alarm system. Depending upon end-users, the global market can be divided into senior care centers, nursing homes, old age homes, hospitals and individual patients.  

In recent times, novel devices are being launched with additional features. For instance, the company Philips has launched a new medical alert system namely, GoSafe that possess an auto-alert fall-detection as well as GPS tracking. Even wearables that are offered by Fitbit are fitted with medical alert systems, additionally to their usual health tracking features. Also, Stealth Technologies, Inc. has introduced a device—911 Help Now—that has no recurring monthly charge. These devices pose threat for standalone MAS devices.

Based on regions, the global medical alert systems market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. In the developed countries such as the U.K., U.S., Canada, they are characterized by high rate of adoption of emergency alert systems from the huge aged population. Also, the market for medical alert systems is anticipated to fuel further in developed countries owing to high rate of incidence of injuries owing to fall from beds and upper bunks.

Due to the presence of various established as well as emerging players in the global market, the global medical alert systems market is highly fragmented,.

The major companies that provide medical alert systems include Galaxy Medical Alert Systems, Ltd., AlertOne Services, LLC., CarelineUK Monitoring Limited, Life Alert Emergency Response, Inc., LifeStation, Inc., Bay Alarm Medical, and Koninklijke Philips N.V.

Hearing aids are devices utilized for the treatment of hearing impairment. It is an electronic sound-amplifying device that consists of varied components such as receiver, microphone, amplifier circuitry, and batteries. These devices intend to capture, amplify and deliver sound into the ear canal. The hearing loss may occur owing to varied reasons such as trauma or injury to the head, aging, prolonged exposure to loud noise, genetic factor and disorders such as Meniere’s disease.

According to the 2015 statistics provided by Royal National Institute for Deaf People (RNID), in the U.K. , around 11 million people suffer from hearing loss and the number is anticipated to grow to 15.6 million by the year 2035. Also, in the year 2014, according to the Centers for Disease Control and Prevention (CDC), over 97% infants were screened for hearing loss. During the period 2005 to 2014, over 45,000 deaf children were born in the U.S.

In 2012, as per the World Health Organization (WHO), over 360 million people were suffering from hearing loss that included 32 million children. In addition in the year 2017, over 1.1 billion people across the world falling in the age group of 12-35 years are at the hearing loss risk owing to continuous noise exposure. Over 60% of childhood hearing loss can be prevented by immunizing children against the disease that results in hearing loss for instance meningitis, rubella, and mumps.

There are three different types of hearing loss, namely mixed hearing loss, conductive hearing loss, and sensorineural hearing loss. The most common type of hearing loss is sensorineural hearing loss. It is also a permanent type of hearing loss that is caused owing to damage to the inner cells or auditory nerve of the ear.

The global hearing aids market can be classified based on product, type of hearing loss, patient type and region. On the basis of product, the global market is classified into hearing aid devices and hearing implants. Further, the hearing aid devices are classified into receiver-in-the-ear (RITE) hearing aids, behind the ear hearing aids, canal hearing aids, in the ear hearing aids and other hearing aid devices. Further based upon type of hearing loss, it is segmented into sensorineural hearing loss and conductive hearing loss. Depending upon patient type, the global market is sub-divided into adults and pediatrics.

Based on regions, the global hearing aids market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. North America commands the majority of the market share, followed by Europe in the global market. Factors such as huge geriatric population and high rate of adoption of devices in this region will help in the market growth. It is anticipated that the rate of growth of hearing aids market will rise in Asia-Pacific region during future period owing to the incessant increase in population in the emerging countries such as China and India. Also, the majority of companies are focusing on emerging economies to capture the market share and expand their customer base in order to meet the high demand from this region.

The major companies that provide hearing aids include William Demant Holding A/S, Sonova Holding AG, Sivantos Inc., Sonic Innovations Inc., Cochlear Ltd., Oticon A/S, Zounds Hearing Inc, SeboTek Hearing Systems, LLC, MED-EL, GN Hearing.

The term sterile injectables are used to refer biologics that are utilized for the treatment of different drugs and possess similar active ingredients as that of the branded drugs. However, there can be various types of inactive contents of the drugs. The manufacturing process of generic sterile injectable is same as that of FDA regulatory terms for the branded counterparts.

As per the latest studies, there are over 2,400 sterile injectable products under development phase that will result in the advent of advanced products in the global sterile injectables market. However, the major driving factor of this market includes generic injectables products market. Large number of pharmaceutical firms is concentrated on development of generic injectables. Owing to the increased focus of firms on therapeutic segments such as oncology, biologics have become an integral component of the pharmaceutical industry’s development pipeline. Also, novel drug delivery systems that offer targeted therapies are gaining importance. Also, the regulatory body has reduced the approval timeline for biologics. These factors are leading to the expansion of sterile injectables market.

However, the expansion as well as manufacturing process of sterile injectable products is very complex and needs large investment. Also, the manufacturing costs of injectable products are high as compared to conventional drugs. Further, the U.S. FDA has imposed complex regulations on manufacturing facilities and equipment. Also, the operational costs of sterile injectables are high as majority of the injectables are toxic as well as infectious in their natural state and, therefore, require high quality and care in their storage, manufacturing, packaging, and distribution. These factors are challenging the growth of sterile injectables market.

The global sterile injectables market can be classified based on technology and region. On the basis of technology, the global market is classified into conventional dosages and novel formulations. Further based upon conventional dosages, it is segmented into solutions, and Lyophilized / Water for reconstitution. Based on novel formulations, the global market is further divided into depot injections, liposomes, nanoformulations, PEGylated formulations and implants.

Based on regions, the global sterile injectables market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the sterile injectables market during the forecast period. The presence of numerous pharmaceutical organizations in the North American market and favorable regulatory environment as well as large population base have led to the high growth rate and high demand for sterile injectables. However, the Asia-Pacific region is anticipated to register swift growth during the forecast period owing to the presence of large number of companies engaged in the development of generic products.

The major companies that provide sterile injectables include Amgen Corporation, Eli Lilly, Sanofi, Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Novartis AG, Abbvie, Novo Nordisk,Genentech,Johnson&Johnson.

Cranium is a critical component of the body, which works as a hard defensive covering of the cerebrum and furthermore helps in keeping up the form and state of the head. In some circumstances owing to early sealing of the sutures, there are a few variations from the norm in the skull that are named as craniosynostosis. In craniosynostosis, the sealing of the sutures happens at an early stage, which brings about the problematic state of the head. Nonetheless, there are surgeries identified with settling these issues. The methodology under these surgeries incorporates the cranial conclusion and fixation framework. Moreover, there are numerous different conditions where cranial closure and fixation devices are being utilized, for example, skull cracks, hematomas, cerebrum tumors, hydrocephalus, and other injury wounds, and diseases.

The mind is an essential piece of human body to perform major crucial functions of the body and its contact to the elements may prompt further diseases that can be muddled later. This further makes the cranial closure devices essential after cerebrum surgery. To access the bone inside an area of the mind is cut opened appropriately according to the working piece of the skull. The cut open area of the mind is named as bone fold that might be huge or little in measure according to the prerequisite of the surgery. After the surgery, the bone fold is set again at a similar place to cover the brain with the assistance of the cranial conclusion and obsession framework, which incorporates plates, meshes, and screws.

Revenue generation in the cranial fixation and fixation devices market is relied upon to be fueled by components such as, an expansion in the quantity of head injury, tumors, aneurysms, and diseases. Latest innovation, surge in device varieties and other physiological factors, for example, the existence of bacteria/virus inside the mind, intrinsic incapacities, and cranial surgeries in treatment for different cerebrum issue and hydrocephalous. This further is required to influence emphatically on cranial fixation and fixation devices market. Furthermore rising accidents and cancer patients universally are driving the cranial fixation and fixation devices market over the forecasted time period. Essential limitations incorporate increasing expense of the practice, problems related to pediatric surgeries, which may unfavorably influence the development in cranial fixation and fixation devices market.

The global cranial closure and fixation devices market is segmented on the basis of product type, indication type, material type, end user and geography. On the basis of product type, the global cranial closure and fixation devices market can be segmented into Screws, Plates, Mesh, Cranial Flap Tube Clamps, Bone Cement, and Others. On the basis of indication type, the global cranial closure and fixation devices market can be segmented into Brain Cancer, Brain Aneurysm, Craniosynostosis, Hydrocephalous, and Others. On the basis of end user, the global cranial closure and fixation devices market can be segmented into Absorbable and Non-Absorbable. On the basis of end user, the global cranial closure and fixation devices market can be segmented into Cancer Research Institute and Hospitals. On the basis of geography, the global cranial closure and fixation devices market can be segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

Some of the major companies in the global cranial closure and fixation devices market are Johnson & Johnson, Medtronic, Integra Life Sciences Corporation, Biomet, Inc, B. Braun Melsungen AG, among others.

Summary
The global Steel Cord market will reach xxx Million USD in 2018 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Steel Cord by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.


Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Normal Tensile (NT)
        High Tensile (HT)
        Others


Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
        Bekaert
        Jiangsu Xingda Steel Cord
        ArcelorMittal
        Hyosung
        Shandong SNTON Steel Cord
        Bridgestone
        Shougang Century
        Tokusen
        Tokyo Rope MFG
        Hubei Fuxing New Material
        BMZ
        Henan Hengxing
        Junma Tyre Cord
        Sumitomo Electric Industries
        Sodetal


Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        Passenger Car Use
        Freight Car Use
        Others


Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa

The electric dental hand piece engine, is ending up more mainstream combined with innovation headways in electrical frameworks. Electric dental hand piece engine is another substitute to air turbine controlled handpiece engine. Electric handpiece now offers dental practitioners the fundamental adjust of charge and control for new helpful and endodontic procedures. The electric dental handpiece is consolidated with high torque and gloats accuracy cutting with less vibration. Forthcoming electrical handpiece engines are more quickened and has upgraded remineralization. New electric dental handpiece engines can frequently be coordinated into a current PC frameworks which likewise offer sans vibration transmission and decreases vitality misfortune. Electric dental handpiece makers are concentrate on ad libbing more on their applications with the goal that a patient has a simple access to a superior personal satisfaction while consolidating solid oral practices. Specialists who have effectively drilled with electric dental handpiece items changed over truly speedy advantages while sorting out a tooth for a crown with an electric dental handpiece. New version electric dental handpieces has an expectation to absorb information. The forthcoming propelled innovation potential to alter dental care by driving extraordinary development and improving the way medicinal services administrations are managed all through the globe effectively.

Electric dental handpiecemarket has impacted the request as of late. In addition, electric dental handpieces has adjusted new advancements for more prominent proficiency to decrease time in evacuating hard tissues and are fundamentally supplanting conventional fast or low speed handpieces in the worldwide market. These electric dental handpiece engine RPMs ranges from 100-400,000, with a consistent torque to slice through the hard tissues. New electric dental handpiece models are offered with programmed switching highlight for endodontics systems, because of which these gadgets are currently increasing greater fame among dental specialists who are looking for greater adaptability in general usefulness and to lessen clamor levels amid working strategies. Electric dental handpiece market is more extended because of rising rates of dental issue. Expanding rate of maturing populace (for the most part in the U.S. market), ascend in number of dental centers and mechanical progression are a portion of the key components driving the development for worldwide electric dental handpiece market. Moreover, expanding social insurance mindfulness and limited time crusading by assembling organizations is likewise fuelling the development of worldwide electric dental handpiece market. Be that as it may, high cost structure of electric dental handpiece gadgets, overwhelming material, and other regular advancements, for example, laser and brand unwaveringness are a portion of the main considerations controlling the development for the electric dental handpiece market.

The global Electric dental handpiece market is segmented on the basis of type, technology, end user and geography. On the basis of type, the global Electric dental handpiece market can be segmented into High Speed Handpieces and Low Speed Handpieces. On the basis of technology, the global Electric dental handpiece market can be segmented into Push Button Dental Turbine Handpiece and Fiber Optic LED Handpiece. On the basis of end user, the global Electric dental handpiece market can be segmented into Clinics, Hospitals, Surgical Centers and Ambulatory. On the basis of geography, the global Electric dental handpiece market can be segmented into North America Latin America, Europe, Asia Pacific and Middle East & Africa.

Some of the major companies in the global Electric dental handpiece market are DENTSPLY INTERNATIONAL, Inc., Medidenta International Inc., Keystone Dental, Inc., Dentflex, NSK, Nouvag, Inovadent, DENTAMERICA INC. and KMD PRECISIÓN EUROPA, S.L. among others.

The treatment designed to enable the recovery process from injury, illness, or disease to a normal condition either by therapy or counseling or both is referred to as rehabilitation.  Large number of equipment is re-usable in nature, and their rate of adoption is increasing among customers.

The rate of adoption of rehab equipment has increased after the enactment of long-term care insurance system in 2000. This trend has led into function improvements as well as design of such equipment, which provides advantages to the aged population and physically challenged people to attain independence and participate in society.

The global rehab equipment market can be classified based on type, body support, exercises, living aids, application, and region. On the basis of type, the global market is classified into mobility equipment, body support devices, exercise equipment, and daily living aids. Depending upon body support, it is segmented into lift and sling. As per exercises, it is divided into upper body and lower body. Based on living aids, it is divided into reading and writing.  Based on application, the global market is divided into physiotherapy and occupational therapy (OT).  Depending on end user, it is divided into hospitals, clinics and home care among others.

Among the major market segments, the mobility equipment segment is set to register the highest growth during the future period owing to the rise in number of elderly people suffering from orthopedic impairments resulting in a demand for mobility equipment across the globe. Also, the physiotherapy market segment is set to register the highest growth during the future years owing to the rising need for physiotherapy among the elderly population & disabled patients and the application of promising government policies.

The global rehab equipment market is set to witness remarkable growth in the forecast period.  Factors such as the rising incidence of disabilities that result from diseases, favorable healthcare reforms, and rise in geriatric population along with the high prevalence of chronic diseases are fuelling the growth of this market. However, high costs & maintenance expense of rehabilitation equipment is expected to hamper the market growth. The various technological advancements such as smart accessible gadgets tend to expand the growth opportunities for this market

Based on regions, the global rehab equipment market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the global rehab equipment market during the forecast period. The increased preference for an independent lifestyle, the need for elderly and physically challenged individuals to discover the world, rise in longevity, and the astounding cost of caregiver services have propelled the demand for mobility devices across the world. Moreover, the U.S. government is increasingly providing support and reimbursement facilities for these equipment.

The major companies that provide rehab equipment include Drive DeVilbiss Healthcare, GF HEALTH PRODUCTS, INC., Stryker Corporation, Access Rehabilitation Group, Amigo Mobility International, Inc., Medline Industries, Inc., Argo Medical, Dynatronics Corporation, Invacare Corporation, and Caremax Rehabilitation Equipment Co. Ltd. among others.

A portion of the components in charge of market development are the high birth rate in creating nations, rising commonness of preterm births, and endeavors by the administration to expand survival rates in such cases. Furthermore, expanding commonness of neonatal doctor's facility gained diseases and rising mindfulness about neonatal wellbeing and care gear is required to add to the development. As indicated by the UN Foundation maternal and baby mind is a worldwide need, since around 800 ladies pass on consistently from preventable causes related with pregnancy or labor. This has prompted expanded interest for neonatal and fetal care gear. Besides, preterm and low weight birth babies are vulnerable to numerous health hazards and require particular care. Consequently, interest for neonatal gear is relied upon to develop exponentially. Neonatal gear has been seen to have expanding request in center pay nations, as birth rates in these nations are higher, and the need for enhanced fetal and neonatal care is high in these nations. Accordingly, offers of the hardware are relied upon to prosper at a quick rate.

In 2016, ultrasound gadgets held the biggest offer inferable from its expanding application to see the hatchling amid pregnancy. Moreover, rising mindfulness, mechanical headways, and straightforwardness in utility have additionally set off the use of convenient and do-it-without anyone else's help ultrasound gadgets for home-utilize. Fetal screens are expected to witness speediest development rate amid the figure time frame, attributable to its utility in deciding the child's heart rate amid pregnancy and work. Fetal checking gadgets are basic as it permits persistent observing of the infant's heart rate and compressions and aids work as well. Observing gadgets section held the biggest offer in the year 2016, inferable from elements, for example, consistent mechanical headways in neonatal screens incorporating changes in network and usability in home settings. Then again, respiratory gadgets are required to display speediest development rate attributable to expanding interest for respiratory care in neonatal with a specific end goal to diminish the length of healing center stay and danger of long haul incapacity. Almost all babies are inclined to respiratory troubles during childbirth, and neonate respiratory gadgets facilitate the procedure guaranteeing better strength of the infant.

The global fatal and neonatal care equipment market is segmented on the basis of type, equipment and geography. On the basis of type, the global fatal and neonatal care equipment market can be segmented into Ultrasound Devices, Fetal Pulse Oximeters, Fetal Dopplers, Fetal Monitors and Fetal MRI Systems. On the basis of equipment, the global fatal and neonatal care equipment market can be segmented into Convertible Warmers & Incubators, Infant Warmers, Phototherapy Equipment, Incubators, Respiratory Devices and Neonatal Monitoring Devices. On the basis of geography, the global fatal and neonatal care equipment market can be segmented into North America. Some of the companies in the fatal and neonatal care equipment market are GE Healthcare, Becton, Koninklijke Philips N.V, Dickinson and Company, Medtronic, THE DRAGER GROUP, Medtronic plc and Philips Healthcare among others.

Active Implantable Medical Device can be defined as an active medical device which is anticipated to be either totally or partially introduced, via surgery or through medical ways, into the human body. It can also be introduced through medical intervention into a natural orifice, and is envisioned to remain there after the procedure. The examples for active implantable medical device include cochlear implants, implantable cardiac pacemakers, bladder stimulators among others.

The global active implantable medical device market is expected to earn major revenue during the forecast period. Factors such as upsurge in geriatric population, varied technological advancements, rising incidence of chronic diseases, and high rate of adoption of advanced implantable medical devices is propelling the growth of this market. However, certain factors such as high cost and limited coverage of insurance schemes for the active implantable medical devices may restrain the growth of this market. In the developed markets, the market for active implantable medical devices market has reached maturity. However, rise in awareness for these implantable devices among populations has augmented the market growth in the emerging countries.

The global active implantable medical device market can be classified based on product and region. On the basis of products, the global market is classified into implantable cardioverter defibrillators, implantable cardiac pacemakers, ventricular assist devices, neurostimulators, and implantable hearing devices. The implantable cardioverter defibrillators are further classified as transvenous or subcutaneous based on their route of insertion in the body.

Among the market segments, the implantable cardioverter defibrillators segment is expected to command a large share of the active implantable medical device market during the future years owing to the increasing incidence of cardiovascular diseases, enormous development of technically advanced devices, and an upsurge in the demand for these devices in emerging economies. is propelling this market segment.

Based on regions, the global active implantable medical device market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the active implantable medical device market during the forecast period. Factors such as high rate of prevalence of cardiovascular as well as neurological diseases, rising investments and funds to develop technically advanced products, extended applications of neurostimulators, and favorable reimbursement schemes for ENT procedures are promoting the growth of this regional market. Also, increased accessibility to advanced technologies, enormous development of innovative as well as advanced products, and rise in healthcare expenditure are fuelling this regions market growth.

The Asia-Pacific region is expected to witness the swiftest growth in the active implantable medical device market. Factors like rise in geriatric population, high prevalence of chronic diseases, increasing healthcare spending, advent of healthcare reforms for infrastructural development, demand for advanced products, and less stringent regulations in this region., are propelling this market in the region.

The major companies that provide active implantable medical device include Medtronic plc, Abbott Laboratories and Boston Scientific Corporation. The other players in this market are BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Limited, MED-EL, Sonova Holding AG and William Demant Holding A/S.  

Digital pathology is the most nascent and emerging technology in the pathology sector. In the current methodology, the glass slides that consist of specimen samples are transformed into digital images for easy storage, observance, analysis, and management of the gathered data. This is empowered in part owing to virtual microscopy that is a technology that helps in popular image posting and transmission over a connected network. The data-rich image forms the base for electronic health records maintenance of the patient population and thus compiles the distributed information in order to build up a central database. The technological advancements in digital pathology is anticipated to overtake the traditional pathology to an advanced level. Digitalization of pathology has resulted in the tests automation during diagnosis, thereby saving cost as well as efforts. For instance, a single digital instrument can conduct the tests that were previously conducted using five instruments by pathologists.

The global digital pathology market is segmented on the basis of product, type, end-users and application. By product, the market is classified into scanners, software, communication system and storage systems. Depending on type, the global digital pathology market is classified into human and animal pathology. Based on end-users, the global digital pathology market is divided into pharmaceutical, hospitals and academic agencies. Depending on application, the global market is divided into tele-consultation, and drug discovery. Based on application, the market is subdivided into drug discovery; and teleconsultation.

Digital pathology plays a vital role in companion diagnostics as well as drug development pipeline that includes molecular tissue profiling, molecular biology, biobanking, and tissue microarray analysis. An increase in demand for high-quality tissue samples in tissue-based biomarker research is fuelling the increased rate of adoption of this technology during the forecast period. The global digital pathology market is set to register an intense competition in the future owing to increase in the rate of adoption of rigorous strategies by the market players in order to retain competition.

Based on regions, the global digital pathology market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the digital pathology market during the forecast period. Factors such as the rise in chronic disease prevalence and increased number of initiatives by major industry players and government in diagnostics sector are propelling the digital pathology market growth. However, the Asia-Pacific region is expected to exhibit highest growth rate during the future period.

The major companies that provide digital pathology include Hamamatsu Photonics K.K, Leica Biosystems Nussloch GmbH, Definiens AG, Corista LLC, 3D Histech Ltd, Philips Healthcare, Apollo Enterprise Imaging Corp., Xifin, Inc., Visiopharm A/S, Ventana Medical Systems, Inc., Omnyx, LLC., among others.

Dental chairs are compact and helps to save space owing to a unique concept that support a practitioner/dentist to streamline their daily tasks. A dental chair has various control units that possess ergonomic features based on sophisticated engineering technologies. Owing to the technological advancements and design, the next-generation dental chairs have come to the market that has latest upgradable features. The instruments that are linked to a dental chair include foot switch, X-ray viewer, imaging system, operating light balance arm and extended tray.

The dental chair is anticipated to increase at a high rate during the forecast period. Factors such as remarkable increase in the oral disease prevalence is considered to have a large impact on the dental equipment demand, among which dental chair are vital. The global dental chair market is also fuelled by the infrastructural advancements both in the medical as well as healthcare sector across the globe. Further in the forecast period, the market is estimated to substantially gain from the technological advancements in the forthcoming years.

The major types of dental chairs present across the globe include orthodontic chairs, examination chairs, oral surgery chairs, and portable chairs. Among these dental chairs, the oral surgery dental chairs demand is comparatively higher, and presently, it is expected to remain high over the future years. However, the demand for other types of dental chairs is also expected to rise at a steady rate across the world. On the basis of end-users, the dental chair market is divided into research & academic institutes, hospitals, and dental clinics.

Based on regions, the global dental chair market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. Europe is analyzed to be the largest regional market for dental chairs equipment. Owing to the rise in patient pool suffering from teeth pertaining disorders is anticipated to fuel the European market for dental chair in the future period. Also, owing to the presence of large number of laboratories, his regional market is expected to gain in the future.

North America commands the second largest share in the global dental chair market owing to the presence of advanced medical and healthcare infrastructure. Also, there is presence of numerous established suppliers of dental chairs in this region. The Asia Pacific regional market excluding Japan is expected to gain a significant share over the future period. The rising awareness among consumers about oral health as well as steady up gradation in healthcare infrastructure is anticipated to drive the APAC market for dental chair in the future years. The major companies that provide dental chairs include DentalEZ Inc., Dentsply Sirona Inc., Danaher, A dec Inc., Technodent, Dexta Corp., Dome Inc., Planmeca Oy, Midmark Corp., and Forest Dental among others.

The global orthopedic devices market size was valued at USD 30.4 Billion in 2016 and is expected to reach USD 43.6 Billion in 2025, growing at a CAGR of over4% over the forecast period. An orthopedic implant is a medical device utilized over a missing bone or joint to provide support to the damaged bone. Stainless steel and titanium alloys are used for the strength of devices and a plastic coating acts as an artificial cartilage. Increasing prevalence of osteoporosis, growing geriatric population base with developing technological advancements are expected to major drivers behind the industry growth over the forecast period.

Increasing efficiency of devices and persistent innovation in the design of equipment, growing prevalence of diabetes and obesity and rising trend of alcohol consumption and smoking are projected to propel the market growth over the forecast period. Novel designs for customized implants based on individual patient’s needs, various tracking devices and real time feedback providing smart implants with microprocessors are further expected to create niche segment for these technologies. Furthermore, gene therapy, 3D printing, tissue engineering, robot-assisted surgical procedures and smart implants have the efficiency to provide preventive and not curative measures which is also anticipated to boost the development of cost-effective devices in the industry.

Demand for various orthopedic implants and devices are expected to increase owing to increasing base of ageing population suffering from various bone disorders. Since, a sizeable chunk of the population is over sixty years of age and as per WHO, population of this age group is expected to reach 2 billion by 2050. Additionally, increasing incidence of orthopedic surgery relatively aware consumers is also driving the growth of the global orthopedic devices market.

Furthermore, new innovation in the field of osteology is also projected to boost the market growth for the development of cost-effective devices. Increasing incidences of sports injuries and road accidents and the growing demand for minimally invasive surgical procedures is anticipated to positively impact the global industry revenue. However, low affordability of expensive surgeries, steep implant costs and dearth of skilled professionals are constraining the orthopedic market growth. Additionally, less expenditure on healthcare in developing countries and obscure reimbursement policies will also hamper the adoption of advanced orthopedic devices over the coming years.

The orthopedic device market is segmented based on types and region. Based on types, the market is bifurcated into upper extremity devices, lower extremity devices, spine orthopedic devices, arthroscopic devices, orthobiologics and braces & support devices. Upper extremity devices are further segmented into elbow radius, shoulder and others whereas lower extremity devices are divided into hip, knee, foot, ankle and others. On the basis of spine orthopedic devices, the market is further segregated into artificial discs, fixation screws, fixation nail/rod, fixation plates and fixation wires. Also, the orthobiologics segment is distinguished into bone cement, bone graft substitute, bone growth factors and others. The spinal implants type segment has also contributed a promising share in the market growth owing to increased effective back treatment devices, rising incidences of back pain and increased demand of less invasive procedures and non-fusion technologies by patients.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The Asia Pacific region holds exemplary growth potential for orthopedic device manufacturers, owing to high population number and around 50% of world’s geriatric population base. The North American region follows the Asia Pacific market owing to increased geriatric population, sophisticated R&D leading to novel orthopedic devices and technological advancements.

Some of the notable players operating in orthopedic devices market space include DePuy Synthes, Medtronic Spinal, Medacta, Zimmer Biomet, NuVasive, MicroPort Scientific Corporation (Wright Medical Group), Smith & Nephew, Stryker, DJO Global, Globus Medical and ConforMIS.

Wearable Medical Devices are also referred as autonomous wearable devices providing medical monitoring or support, over a prolonged period of time which are either embedded into the clothes or worn as an accessory. These wearable devices are usually non-invasive physiological sensors providing medical feedback through processing modules and also have wireless data transmission capacity.

Wearable medical devices are small, unobtrusive and light-weight and are designed for operation by unskilled users Since, wearable medical devices are non-invasive, flexible and easier to use and hence, are replacing the traditional diagnostic methods. Alerting mechanism, real time feedback, decision support and wireless access to information are few latest developments leading to the more adoption of the wearable devices.

Increasing penetration of smartphones and rising number of smartphone based healthcare applications compatible with devices is expected to spur the market demand over the forecast period. Furthermore, growing awareness about physical fitness and increasing preferences for wireless connectivity among the healthcare providers is also projected to impact the industry growth positively.

Reduced need for visiting the doctor for simple diagnostic procedures is considered to be one of the driver driving the market growth. Consequently, patients, diagnostic centers, pathology labs, specialty clinics and doctors themselves prefer wearable medical devices over the traditional diagnostic methods. The data produced is electronically transferred to the doctor for analyzing the important incidences with the patient. Various mobile applications are also capable for notifying the erratic changes in the body’s temperature which can help the physicians to understand the root cause behind the instabilities. The physician can therefore describe the guidelines for the patients and recommend prohibitions behind the irregularities in the report. Wearable devices are also capable of remote healthcare since, the devices are equipped with Electrocardiograph (EKG) which can monitor patients’ heart activity. Manufacturers are also developing sensors for breathing which can monitor respiration and blood pressure (BP) while registering critical changes. Devices like electroencephalogram (EEG) are equipped with complex sensors that records muscle activity via stimulations within the user’s brain.

Advanced medical wearables also facilitate instant connectivity with cloud. Thus, concerned medical personal will be informed about the irregularities with the patient’s health, allowing crucial steps to be taken in time for the patient’s health.  Furthermore, growing accuracy of medical devices in remote monitoring of patients is expected to comfort doctors for therapy based on the data recorded through these devices.

The market of wearable medical devices is segmented into patches, smartwatches, smart clothing, and activity monitors. Activity monitors is expected to acquire the largest share of the wearable medical devices market. Key factors responsible for the growth —includes rise in adoption of sedentary and unhealthy lifestyle, increase in the number of diseases pertaining to lifestyle and growing awareness of health and fitness among consumers. Wearable medical devices have application in various arenas including remote patient monitoring devices, home based healthcare and sports and fitness. Sports and fitness application segment is expected to witness highest compound annual growth over the forecast period. The segment growth is attributed to the popularity of the trend to track one’s health progress and the increased focus of people on the respective physical fitness, thereby improving the quality of life.

Stringent regulatory norms provided by the Food and Drug Administration (FDA) for apps for recording critical data may hamper the market growth. However, the wearable medical devices pertaining to diabetes management, fitness apps and similar medical intentions are steering clear of the FDA. Healthcare wearables are an evolving product segment in the global medical devices industry. Rapid innovation and the potential to decrease the cost of regulatory compliance, allowing a stable ground for the manufactures to flourish in the market.

North America regional market is projected to dominate the wearable medical device market, followed by Europe which can be attributed to the developed healthcare infrastructure, technologically advanced healthcare apps and the presence of key market players in these regions. Asia Pacific region is yet to catch up with this technology and hence, has huge potential for growth.

Wearable Medical Devices have a highly competitive market comprising big and small companies. Some of the key players include Philips (Netherlands), Fitbit (US), Garmin (Switzerland), Omron (Japan) and LifeWatch (Switzerland). Other players that are also operating in this market include, Nokia Technologies (US), Drägerwerk (Germany), Polar (Finland), Jawbone (US), ActiveInsights (UK), World Global Network (US), Xiaomi (China), VitalConnect (US), Monica Healthcare (UK), and Misfit (US).

Point-of-care Diagnostic (POCD) is defined as medical diagnostic technology that can be used at the point of care i.e. wherever the patient is present. The diagnostic technique is very different from the traditional testing methods. In traditional diagnostic tests, the diagnostic tests were performed at their respective laboratories and patients had to wait for days for the results, point-of-care diagnostic involves bringing the diagnostic tools immediately and conveniently to the patient and providing rapid diagnosis in real time.

The driving notion of point-of-care diagnostic is its quick diagnostic techniques which allow faster treatment, medication and clinical management based  on the POCD results.. Point-Of-Care Diagnostics includes development in microfluidic, biosensors, assay formats, bio-analytical platforms, lab-on-a-chip technologies and complementary technologies.

Point-of-care diagnostic gathers the specimens and procure results in a short span of time, essentially near the location of the patient such that the cost of treatment is cheaper, quicker and more precise. From management of patient’s data to diagnosis and monitoring of a disease, POCD facilitates all of the tasks for a patient requiring rapid detection.

POCD also plays an important role in patient management, reducing the time required to treat an ailment and improves the ultimate outcome of patient’s health. Since, there are a vast number of point-of-care assays i.e. assays performed on patients, various biomarkers have been developed by deploying portable and simple in usage point-of-care clinical and biochemical analyzers. This is considered to be a revolutionary for many diseases, particularly the ones that require immediate assistance like ischemic stroke. Even for various other diseases, treatment and medical intervention at an early stage would be responsible for saving a lot of lives.

Some examples of equipment being used for improved Point-Of-Care Diagnostics includes label-free biosensors such as white light reflectance spectroscopy (WLRS) and Surface Plasmon Resonance (SPR). Complementary technologies such as system integration, microfluidics, lab-on-a-chip technologies, signal readout and device automation are propelling the Point-Of-Care Diagnostics towards continuous improvements over the forecast period.

Point-Of-Care Diagnostics disposed towards smart devices equipped with mobile healthcare (mH) is predicted to be the major trend in the market, since, this could be particularly revolutionary for POCD and personalized healthcare monitoring and management. Many promising mobile healthcare technologies have been developed that are being used for a readout of colorimetric, lateral flow, electrochemical, fluorescent, chemiluminescent , label-free assays, detection of cells, biomolecules, nanoparticles, and microorganisms and other diagnostic applications using the cellphone-based POC technologies.

It has been estimated that the number of cellphone users have passed 7.4 billion in emerging countries which is 70% of the total cellphone users and the population in these countries is marred by various communicable/non-communicable diseases. Hence, Point-Of-Care Diagnostics could be a revolutionary aid in treatment procedures in the region. Therefore, emerging countries is projected to be a highly profitable market for Point-of-Care Diagnostics.

Some of the major stakeholders in the Point-Of-Care Diagnostics market include various medical device manufacturing companies, companies distributing POCD equipment, clinical laboratories, hospitals, clinics and special areas such as sports and military fitness bodies, government /private research institutes and clinical research organizations (CROs). Establishment of an international cloud for ease in management of Big Data may hinder the market over the forecast period, since, the technology requires personal data of patients, therefore, effective measure would be required for security of privacy of data storage.

The POCD market is set to witness a rise owing to a global demand of a technology facilitating self-monitor and management of the personal health. Roche (Switzerland), Abbott (US) and Siemens (Germany) are the prominent players in Point-Of-Care Diagnostics acquiring the major share in the industry. Various other companies like Instrumentation Laboratory (US), Nova (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Quidel (US), EKF Diagnostics (UK), Chembio Diagnostics (US), Trinity Biotech (US), and AccuBioTech (China) are set to enter the market with their respective products for Point-of-Care Diagnostics.

Patient Warming devices are utilized by physicians and nursing staff for better care of the patients during surgeries, patient transfer, severely injured or diseased patients in acute care settings and anesthesia treatment for warming the patients. For various surgical procedures, anesthesia is of absolute importance for patient’s controlled pain, breathing, blood pressure, blood flow, and heart rate and rhythm. However, when the patient body is under the effect of anesthesia, the body is unable to regulate the temperature. Since, body’s physiological response to anesthesia places virtually every anaesthetized surgical patient at risk for unintended hypothermia regardless of sex, age or physical condition, it was an absolute necessity to find other means to maintain the temperature of the body.

According to a research, the core body temperature drops rapidly (up to 1.6ºC in the first hour alone) which is followed by induction of anesthesia. An unintended hypothermia is extremely dangerous and is a fairly common reason for complications in surgery resulting in an increased rate of wound infection, longer hospital stays and higher mortality rates.

 Increasing geriatric population, growing number of surgical procedures are few factor responsible for spurring the market growth. Furthermore, rising prevalence of oncology and cardiovascular conditions, brain injuries and strokes are also driving the industry growth over the forecast period. Increasing number of surgical procedure, and increasing awareness about various beneficial devices among the healthcare professionals has created substantial opportunities in the market.

The global patient warming devices market has been segmented by product type, application and end-users. Based on product type, the market has been segregated into surface warming systems, intravascular warming systems and patient warming accessories. The product type segment is expected to retain dominance over the market over the forecast period owing to brand image of a safe, efficient, simple to use, and low cost device. Based on application, the global market has been bifurcated into acute care, perioperative care, new born care, and others. The global market by end-user segment has been divided into hospitals, clinics, nursing facilities, and others.

However, technology has made unintended hypothermia easily preventable by using devices giving external warmth to the patients while being operated. Various devices maintain a core temperature of 36.0ºC or higher is helpful in improving outcomes of surgery by reducing the frequency of complications often associated with unintended hypothermia. Forced-air warming device is one of the most widely utilized devices which offers a simple, safe and a cost-effective method to prevent unintended hypothermia and complications associated with it.

North America region is expected to acquire major revenue share owing to presence of the most advanced and sophisticated healthcare facilities in the region. The factors including growing number of surgeries, technological advancements, well-established health care infrastructure, with increasing awareness level are actually responsible for the growth. North American market is followed by the Asia Pacific region, owing to the growing awareness among the people across the region.

Some of the key players of the Patient Warming Devices market include GE Healthcare, 3M Health Care, Cincinnati Sub Zero, C. R. Bard, Inc., Smiths Medical, Inspiration Healthcare Group plc, Covidien PLC, Medtronic plc, Philips Healthcare, ZOLL Medical Corporation and Stryker Corporation.

Deep brain stimulation is a technique that comprises implanting electrodes within specified areas of a patient’s brain. Such electrodes are also known as “brain electrodes” and they emit electrical impulses that regulate abnormal impulses caused by various neurological diseases. The amount of stimulation in this technique is controlled by a device resembling pacemaker that is set beneath the skin on the upper chest of the patient. A connecting wire travels beneath the patient’s skin to the electrodes in the patient’s brain.

Deep brain stimulation (DBS) device is essentially utilized to alleviate symptoms of Parkinson’s disease (PD) as once implanted at one of the three FDA approved brain sites, these electrodes block the electrical signals from these sites to the brain. Namely, Ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN) and globus pallidus pars interna (GPi) are the three FDA approved targeted brain sites for combating Parkinson’s.

One of the most essential factors fuelling DBS market is the increasing cases of Parkinson’s disease. Although there are various surgical options available i.e such as thalamotomy, pallidotomy etc, deep brain stimulation stands as the most widely preferred surgical option owing to the absence of tissue destruction and reversible nature of the surgical treatment. Thus, owing to the fewer complications of this surgical treatment, this market is estimated to grow substantially over the forecast period.  Medtronic’s device Activa PC+S system is a closed-loop DBS device capable of developing an algorithm of the closed-loop system while simultaneously recording the electrical activities in brain. This device is anticipated to be tested positive for a permanent treatment of advanced Parkinson disease. Advent of such devices in the market is projected to benefit patients suffering with Parkinsons, thereby augmenting the deep brain stimulation devices market.

Long term medication which is relatively steep in nature makes treatment of Parkinson and Alzheimer disease extremely unaffordable to a huge section of the population in emerging economies. DBS, on the other hand is a minimally-invasive technology with a long term solution for such chronic ailments. This factor has led to the increased demand for such procedures and devices to aid in the treatment of chronic disease conditions such as blood clot, diabetes, Parkinson’s disease, Alzheimer’s disease and stroke thereby augmenting the deep brain stimulation devices market.

Various novel applications of deep brain stimulation devices particularly for Alzheimer and tinnitus treatment are expected to create new opportunities in the market. Additionally, medical professionals increasingly prefer deep brain stimulation techniques over drug therapy in order to avoid numerous side effects, thereby boosting the demand for global deep brain stimulation devices. However, high cost of devices and increased risk of infection due to implantation of foreign object in the body, battery failure and allergic reaction may constraint the growth of deep brain stimulation device market.

The global deep brain stimulation devices market is segmented into DBS type Application and Geography. On the basis of DBS types, the market is segregated into Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS and Pedunculopontine nucleus DBS. Based on application, the market is bifurcated into pain management, epilepsy, obsessive compulsive disorder (OCD), depression, parkinson disease, essential tremor and dystonia. Geographically, the market is segmented into four regions namely North America, Europe, Asia Pacific, Middle East and Africa and .Latin America.

Some of the major market players have adopted the strategy of acquisition for enhancing the DBS market. For instance, Neurotech has been acquired by Sorin group in order to increase its product portfolio in the DBS market. The companies profiled in this report are Medtronic, Boston Scientific Corporation, Enteromedics, Cyberonics, St. Jude Medical, Neuropace, Zynex, Neuronetics, Functional Neuromodulation, Microtransponder and Neurosigma.

Electroceuticals are a novel category of therapeutic agents/medical devices which target the neural circuits of organs thereby stimulating the nerves and relieving or alleviating the body of various conditions. The therapy encompasses mapping of neural circuitry and delivering neural impulses to specific targets. Electroceuticals are highly target specific and affect the body temperature instead of affecting the body chemistry unlike pills which in turn leads to various side effects and hence, are emerging as an alternative to pharmaceuticals.

Technological advancements in electroceutical products have propelled their adoption in treatment of medical conditions associated with central nervous system and chronic diseases such as cardiac arrhythmias and Parkinson's. The technologically advanced electroceuticals are highly efficient and reliable during treatment thereby propelling the market growth. Increase in geriatric population prone to chronic medical conditions is also estimated to fuel the market growth owing to various applications of electroceutical devices in providing better patient care.

Cost effectiveness nature of this therapy is also a driving factor for augmenting the market growth. Furthermore, growing investments and funds for the development of novel therapies by key players of the industry for developing better electroceutical devices is anticipated to enhance the market growth.  However, lack of self-regulating measurement, miniaturization in terms of electrodes or chip which can interface with single nerve and the devices must be wireless with elimination of traditional batteries are some of the challenges faced by electroceutical market.

The Electroceutical Devices market is segmented based on type, application and end-user. On the basis of type, the market is further segregated into internal and external type. Internal electroceutical devices are designed to deliver electrical currents after being placed inside the body through minimally invasive procedures.  External electroceutical devices are stimulation devices which are placed or moved at specific locations outside the body where it provides neuromodulation/neurostimulation

The internal electroceutical segment is expected to hold the largest market revenue in 2015 and is projected to grow during the forecast period at a high CAGR owing to technological advancement in wireless micro current stimulation, wearable pain management technology, miniaturization. Based on the application, the segment includes hearing aids, gastroenterology & Urology, pain management, cardiology, central nervous system and others. The cardiology segment is expected to account for the largest share of the market during the forecast period. On the basis of end-users, the market is segmented into hospitals and home-care. The hospitals segment is expected to hold the largest share of the market over the forecast period whereas the individual users segment is anticipated to be the fastest growing market.

Geographically, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America. North America region is expected to acquire major share and is projected to witness moderate growth over the forecast period. High investments in healthcare infrastructures with favorable reimbursement coverage have contributed to market growth in this region. Asia- Pacific region is also projected to witness enormous growth over the forecast period owing to growing healthcare awareness, increasing government funding, improved economic growth, large patient pool and proliferation in the geriatric population thereby increasing the number of surgeries.

Also, heavy investment made by various private and government owned organization to fund the research on electroceutical products is also expected to drive the industry. For instance, GSK (GlaxoSmithKline) has invested $50 million in action potential venture fund on five start-ups companies for conducting research on electroceutical and $5 million for its own Bioelectronic research center at GSK. Around 33 electroceuticals funded by GSK are in their early research stages and are set to be tested on humans since its prototype based on animal testing is already in the market. In August 2016, GSK and Google spinoff Verily Life Sciences entered a joint venture to form Galvani Bioelectronics to work on R&D and commercialization of bioelectronics or electroceutical devices. GSK and Verily Life Sciences would provide funding close to $715 million over 7 years. The initial research is concentrated on treating inflammatory, metabolic and endocrine disorders, type II diabetes and disease caused by zapping nerves. Furthermore, National Institute of Health (NIH) of U.S is investing heavily and has announced funds of $248 million for development of electroceuticals.

Major players in the electroceuticals market include Cochlear Limited, St. Jude Medical, Inc., Medtronic plc, Nevro Corporation, LivaNova PLC, ElectroCore LLC, Boston Scientific Corporation, Sonova Holding AG, Biotronik, and Second Sight Medical Products, Inc.

A bone densitometer (BDM) is a device used to measure the amount of bone density or mass of mineral per unit volume. There has been a substantial rise in number of patients suffering from Paget's disease, and osteogenesis arthritis, osteoporosis in post-menopausal women and vitamin D deficiency. This unprecedented rise has led to increasing demand for BDM, thereby expanding the potential market over the forecast period.

BDM uses a invisible, thin, low-dose X-ray beam. In the scanning processes, the two beam penetrates the bone, one is for the bone, other is for the soft tissue absorption. The quantity for the soft tissue absorption is subtracted from the bone absorption quantity and remaining left quantity is the bone density of patient. The meter utilizes the special software which analyses the bone density automatically and displays the result on the monitor.

The equipment includes a central device and a peripheral device (pDXA) occasionally. Both the equipment are referred as DEXA or DXA equipment. The central device is utilized to measure the bone density in the spine and hip and are majorly employed in the hospital or medical practice setting. For smaller bones such as heel, wrist, or finger, peripheral device can be used for scanning.

BDM is achieving prominence globally, particularly in countries witnessing frequent screenings owing to a rise in aging population affected by bone-related & chronic diseases and availability of improved treatments.  The meter ensures improved turnaround time, cost benefit, and increased patient satisfaction. According to the Osteoporosis Canadian , one in three women and one in five men are likely to suffer from osteoporotic fracture in their life.

The technological advancements of BDMs with ease of availability, various medical tourism initiatives and acknowledgment of the devices in emerging economies, such as Brazil, Japan, China, and India, are expected to enhance the growth opportunities for the industry player. over the forecast period. Advancement of portable devices, cost containment measures, and increased awareness for early diagnosis are anticipated to play vital role in growth of the industry..

The results are needed to calculate with care which can deduce false results owing to artifacts, location, anatomy, varying technician as well as machinery results to restrain the market growth. However, specialty clinics, diagnostic centers, and hospitals are the leading end users creating strong opportunities for the market over the forecast period.

The market is broadly segmented by technology, services and application. Based on technology, the segment is bifurcated into Axial Bone Densitometry, Dual-energy X-ray absorptiometry (DEXA), Peripheral Bone Densitometry, and others. Others technology includes SEXA, Quantitative Computed Tomography (QCT), peripheral Dual-energy X-ray absorptiometry (pDEXA), Quantitative Ultrasound (QUS), RA, and peripheral Quantitative Computed Tomography (pQCT). On the basis of services offered, the market is segmented as Tele-Consultation, Tele-Training Tele-Education, Tele-Surgery, and Tele-Monitoring.

Based on their application, the market is segmented as Hospitals, Diagnostic Centers, and Specialty Clinics. Hospitals have emerged as the key applicant for bone densitometers followed by diagnostic centers owing to rising preference of patients for medical facilities and well-equipped infrastructure. The inclination of government healthcare organizations to provide fully automated systems and advanced diagnostic instruments producing rapid results is also one of the prime factors accountable for the considerable share of the segment.

North America region is expected to acquire the major share of the market. The collaboration among the major industry players for maintaining high medical standards and improved R&D proficiencies are estimated to drive the market across thie region. Infrastructural improvements in healthcare facilities, high disposable income, and large number of osteoporosis patients are projected to apprehend the major share in the region. Increasing awareness related to osteoporosis in the emerging economies of APAC region such as China and India will also generate new growth opportunities over the forecast period.

GE Healthcare, Beammed Ltd., Swissray International Inc., Hologic Inc., Osteometer Meditech, Osteosys Co. Ltd., Medonica Co. Ltd., Diagnostic Medical System SA, and Lone Oak Medical Technologies LLC are some of the prominent players of global bone densitometers market. The other strategies amalgamated in these players are new product development, high R&D investment, agreements and mergers & acquisitions.